Govt launches portal to monitor public procurement from MSMEs (See 'TOG News')GST: Law Review Committee to examine Advisory Group's recommendations (See 'TOG News')State govt to link grievance cells with Centre (See 'TOG News')TP - No TP adjustment can be made in case of AMP expenses incurred for promoting brand of AE, by applying bright line test on protective basis: ITAT (See 'TOG Latest')Income Tax - Revenue cannot proceeded to invoke section 14A read with Rule 8D without recording his dis-satisfaction: ITAT (See 'TOG Latest')Central Excise - When assessee failed to fulfil requirement as under Rule 6(2) during period of dispute, duty demand raised for recovery of credit is sustainable: CESTAT (See 'TOG Latest')Customs - Even if assessee did not ask adjudicating authority to grant personal hearing, it was incumbent to provide them such opportunity of personal hearing: CESTAT (See 'TOG Latest')ESI corporation forms society to maintain State dispensaries (See 'TOG News')Govt extends deadline for Aadhaar-PAN linking to March 31, 2018TP - No separate addition on account of 'interest on delayed receivables from AEs', is required, if working capital adjustment has already been allowed: ITAT (See 'TOG Latest')Income Tax - Penalty cannot be imposed if assessee is not made aware as to under which of two limbs of Sec. 271(1)(c) of Act penalty has been imposed: ITAT (See 'TOG Latest')GST - Fresh allegation cannot be raised in penalty order, where such allegation absent in SCN: HC (See 'TOG Latest')Central Excise - Co-operative society claiming exemption does not mandatorily need registration in same area where manufacturing unit is located: CESTAT (See 'TOG Latest')24x7 power is fundamental right of every citizen: Power Min (See 'TOG News')TP - While evaluating ALP, TPO is not permitted to seek justification from Assessee regarding receipt of benefits in lieu of services offered to its AEs: ITAT (See 'TOG Latest')Income Tax - Expenditure incurred on brand advertisement can be allowed as Revenue Expenditure: ITAT (See 'TOG Latest')Custom - Penalty cannot be imposed on CHA where fraud involving import license occurred after clearance of goods: CESTAT (See 'TOG Latest')Central Excise - Garden & office maintenance expenses eligible for credit, where incurred in compliance with State Pollution Board norms: CESTAT (See 'TOG Latest')Four aspects of International Transaction (See 'TOG INSIGHT')
Tax on Go
Budget 2015
Click the banner to download Documents
HOME       GST     INDIRECT TAX     INCOME TAX     DTAA     TP     MIXED BAG     LIBRARY    

TOG NEWS

Coordination between regulatory authorities & pharma sector will promote new technologies: Govt
By TOG News Service
Nov 21, 2017

TOG News Service, NEW DELHI, NOV 21, 2017: To enable a holistic view on access to medicines, including all medical products, the Ministry of Health & Family Welfare, Government of India and Indian Society of International Law with the support of World Health Organisation (WHO) has innaugurated 1st World Conference on Access to Medical Products and International Laws for Trade and Health in the Context of the 2030 Agenda for Sustainable Development, here on November 21, 2017.

The Union Minister of Health and Family Welfare, Mr. J P Nadda has stated that there is a need for promoting industry and academia collaboration for developing affordable medical products such that innovations and advances in medical sector reach a vast population. India is deeply committed nationally and globally in achieving all public health goals and also focusing on developing India as a hub for affordable medical devices, he added. Highlighting the importance of transparency between regulatory authorities and pharma sector, Mr. Nadda stated that the coordination between the National Regulatory Authorities and pharmaceutical sector will enable launch and registration of new health technologies. He further said that the dialogue on role of competition in competitive pricing and discussion on related WTO agreements influencing health should lead to a larger umbrella of suggested policy options for the government.

Addressing the conference, Mr. Ashwini Kumar Choubey, Minister of State (HFW) said that research and development in public health should focus on two main aspects. To enable safe, effective and quality medical products for the diseases and rolling out the innovations and inventions along with the learning's from the field to the people. He further stated that the research and development should focus on making the cost of medical devices or products affordable to the people and highlighted the issue of Anti-microbial Resistance (AMR).

Dr. V.K. Paul, Member, NITI Aayog, Govt. of India stated that there is a need for investment in medical products for preventive therapy and treatment and highlighted the importance of affordability, quality, domestic production capacity and to create an eco-system of policy and innovation for greater accessibility of affordable medical drugs and devices. Dr. Paul further said that technology is an integral block for strengthening medical systems in any country and must also ensure timely maintenance of medical equipment by suppliers in remote and rural areas such that equipment functions effectively.